{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T23:36:27Z","timestamp":1774740987405,"version":"3.50.1"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>\n                      Kratom (\n                      <jats:italic toggle=\"yes\">Mitragyna speciosa<\/jats:italic>\n                      ) is a psychoactive herbal product increasingly used for pain, anxiety, and opioid withdrawal. Although marketed as a natural dietary product, concerns have emerged regarding adverse effects like cardiotoxicity, seizures, opioid-like physical dependence, and, particularly, liver toxicity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a systematic review following PRISMA 2020 guidelines of all studies on kratom use and liver toxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Thirty-one studies were included, comprising 32 cases of kratom-associated liver injury. Most reports originated from the United States and were single-patient case reports. Most patients were adult males, with frequent co-occurrence of polysubstance use and comorbid conditions. Concomitant exposures were commonly reported but variably characterized across studies. Baseline liver disease was present in 3 patients (9%). Kratom dose, form, frequency, and duration were inconsistently reported. Only 7 cases (22%) provided complete exposure details, whereas the remainder lacked one or more elements. Kratom use was temporally associated with the onset of liver injury, commonly presenting with jaundice and elevations in liver enzymes. The patterns of injury were predominantly cholestatic. In most cases, liver enzymes and function improved after cessation of kratom use. In 4 cases, the patient\u2019s liver function did not improve and progressed to liver transplantation. Although formal causality assessments were inconsistently reported, many reports supported an association based on exclusion of alternative etiologies and, in some cases, rechallenge episodes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Further research is needed to better characterize kratom\u2019s mechanisms of liver injury and to inform clinical decision-making and public health policy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/adm.0000000000001663","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:00:18Z","timestamp":1773115218000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Liver Injury Associated With Kratom (Mitragyna specios a): A Systematic Review"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3432-7194","authenticated-orcid":false,"given":"Xavier Alexander","family":"Calicdan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anika","family":"Kopczynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Sotelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander Chen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"issue":"6","key":"R1-20260310","doi-asserted-by":"crossref","first-page":"101442","DOI":"10.1016\/j.disamonth.2022.101442","article-title":"Kratom: history, pharmacology, current user trends, adverse health effects and potential benefits","volume":"69","author":"Grundmann","year":"2023","journal-title":"Dis Mon"},{"key":"R3-20260310","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jdcr.2022.07.033","article-title":"Kratom as a novel cause of photodistributed hyperpigmentation","volume":"28","author":"Powell","year":"2022","journal-title":"JAAD Case Rep"},{"key":"R4-20260310","doi-asserted-by":"crossref","first-page":"1403140","DOI":"10.3389\/fphar.2024.1403140","article-title":"Kratom safety and toxicology in the public health context: research needs to better inform regulation","volume":"15","author":"Henningfield","year":"2024","journal-title":"Front Pharmacol"},{"issue":"9","key":"R5-20260310","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1021\/jm010576e","article-title":"Studies on the synthesis and opioid agonistic activities of mitragynine-related indole alkaloids: discovery of opioid agonists structurally different from other opioid ligands","volume":"45","author":"Takayama","year":"2002","journal-title":"J Med Chem"},{"key":"R6-20260310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02791072.2025.2474249","article-title":"Prevalence and use patterns of kratom (Mitragyna speciosa Korth.) in a US Nationally Representative Sample","author":"Grundmann","year":"2025","journal-title":"J Psychoact Drugs"},{"key":"R7-20260310","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.drugalcdep.2017.03.007","article-title":"Patterns of Kratom use and health impact in the US\u2014results from an online survey","volume":"176","author":"Grundmann","year":"2017","journal-title":"Drug Alcohol Dependence"},{"issue":"2","key":"R9-20260310","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/17512433.2024.2305798","article-title":"An update on the clinical pharmacology of Kratom: uses, abuse potential, and future considerations","volume":"17","author":"McCurdy","year":"2024","journal-title":"Expert Rev Clin Pharmacol"},{"key":"R10-20260310","doi-asserted-by":"crossref","first-page":"108426","DOI":"10.1016\/j.drugalcdep.2020.108426","article-title":"Liver injury associated with kratom, a popular opioid-like product: experience from the U.S. drug induced liver injury network and a review of the literature","volume":"218","author":"Ahmad","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"R11-20260310","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40265-019-01242-6","article-title":"Kratom (Mitragyna Speciosa) liver injury: a comprehensive review","volume":"80","author":"Schimmel","year":"2020","journal-title":"Drugs"},{"issue":"4","key":"R14-20260310","doi-asserted-by":"crossref","first-page":"e00715","DOI":"10.14309\/crj.0000000000000715","article-title":"Kratom (Mitragyna speciosa)-induced hepatitis","volume":"9","author":"Allison","year":"2022","journal-title":"ACG Case Rep J"},{"issue":"4","key":"R15-20260310","first-page":"e14679","article-title":"Kratom-induced liver injury: a case series and clinical implications","volume":"13","author":"Botejue","year":"2021","journal-title":"Cureus"},{"key":"R16-20260310","doi-asserted-by":"crossref","first-page":"2324709619836138","DOI":"10.1177\/2324709619836138","article-title":"Kratom-induced cholestatic liver injury and its conservative management","volume":"7","author":"Fernandes","year":"2019","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"2","key":"R17-20260310","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.JAA.0000805820.94245.3d","article-title":"Acute liver injury following short-term use of the herbal supplement kratom","volume":"35","author":"Umbehr","year":"2022","journal-title":"JAAPA"},{"issue":"2","key":"R18-20260310","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jhep.2023.04.026","article-title":"Kratom-induced acute liver injury: a case study and the importance of herbal supplement regulation","volume":"79","author":"Roma","year":"2023","journal-title":"J Hepatol"},{"issue":"4","key":"R19-20260310","doi-asserted-by":"crossref","first-page":"e546","DOI":"10.1097\/MJT.0000000000000802","article-title":"Herb-induced liver injury with cholestasis and renal injury secondary to short-term use of Kratom (Mitragyna speciosa)","volume":"26","author":"Antony","year":"2019","journal-title":"Am J Ther"},{"key":"R20-20260310","doi-asserted-by":"crossref","first-page":"11795476221132824","DOI":"10.1177\/11795476221132824","article-title":"Kratom-associated mixed gholestatic-hepatocellular liver injury in a patient with long COVID: a case report","volume":"15","author":"Thewjitcharoen","year":"2022","journal-title":"Clin Med Insights Case Rep"},{"issue":"1","key":"R21-20260310","doi-asserted-by":"crossref","first-page":"79","DOI":"10.14740\/gr990e","article-title":"Histologic characterization of kratom use-associated liver injury","volume":"11","author":"Riverso","year":"2018","journal-title":"Gastroenterol Res"},{"issue":"8","key":"R22-20260310","doi-asserted-by":"crossref","first-page":"e00647","DOI":"10.14309\/crj.0000000000000647","article-title":"Multiorgan dysfunction related to kratom ingestion","volume":"8","author":"Khan","year":"2021","journal-title":"ACG Case Rep J"},{"issue":"4","key":"R23-20260310","doi-asserted-by":"crossref","first-page":"211","DOI":"10.14740\/gr1204","article-title":"Kratom-induced cholestatic liver injury mimicking anti-mitochondrial antibody-negative primary biliary cholangitis: a case report and review of literature","volume":"12","author":"Aldyab","year":"2019","journal-title":"Gastroenterol Res"},{"issue":"10","key":"R24-20260310","doi-asserted-by":"crossref","first-page":"863","DOI":"10.4254\/wjh.v12.i10.863","article-title":"Kratom induced severe cholestatic liver injury histologically mimicking primary biliary cholangitis: a case report","volume":"12","author":"Gandhi","year":"2020","journal-title":"World J Hepatol"},{"issue":"3","key":"R25-20260310","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s13181-011-0155-5","article-title":"Intrahepatic cholestasis following abuse of powdered Kratom (Mitragyna speciosa)","volume":"7","author":"Kapp","year":"2011","journal-title":"J Med Toxicol"},{"key":"R26-20260310","doi-asserted-by":"crossref","first-page":"2324709619826167","DOI":"10.1177\/2324709619826167","article-title":"Drug-induced liver injury caused by Kratom use as an alternative pain treatment amid an ongoing opioid epidemic","volume":"7","author":"Osborne","year":"2019","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"3","key":"R27-20260310","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/20009666.2018.1468693","article-title":"Kratom: a dangerous player in the opioid crisis","volume":"8","author":"Tayabali","year":"2018","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"2","key":"R28-20260310","first-page":"110","article-title":"Kratom-induced acute cholestatic liver injury: a case report","volume":"19","author":"Hairane","year":"2023","journal-title":"J Med Toxicol"},{"key":"R29-20260310","first-page":"121","article-title":"Recurrent Kratom-induced hepatotoxicity from herbal tea ingestion: two times isn\u2019t a charm","volume":"60","author":"Schmitz","year":"2022","journal-title":"Clin Toxicol"},{"issue":"6","key":"R30-20260310","doi-asserted-by":"crossref","first-page":"S-852","DOI":"10.1016\/S0016-5085(21)02765-7","article-title":"Opiate-like herbal supplement as cause of drug induced liver injury: a case of kratom-induced liver injury","volume":"160","author":"Alias","year":"2021","journal-title":"Gastroenterology"},{"issue":"2","key":"R31-20260310","first-page":"143","article-title":"Kratom (mitragynine speciosa) induced acute liver failure","volume":"16","author":"Fishburn","year":"2020","journal-title":"J Med Toxicol"},{"issue":"(Pronesti V.; Sial M.; Talwar A.","key":"R32-20260310","first-page":"S1344","article-title":"Cholestatic liver injury caused by kratom ingestion","volume":"114","author":"Pronesti","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"R33-20260310","doi-asserted-by":"crossref","first-page":"S-1316","DOI":"10.1016\/S0016-5085(19)40307-7","article-title":"Kratom induced cholestatic hepatitis","volume":"156","author":"Ricardo","year":"2019","journal-title":"Gastroenterology"},{"issue":"6","key":"R34-20260310","first-page":"527","article-title":"Severe liver injury caused by recommended doses of the food supplement kratom","volume":"57","author":"B\u00f8gevig","year":"2019","journal-title":"Clin Toxicol"},{"issue":"10","key":"R35-20260310","first-page":"947","article-title":"Salmonella contaminated Kratom ingestion associated with fulminant hepatic failure requiring liver transplantation","volume":"56","author":"Mackenzie","year":"2018","journal-title":"Clin Toxicol"},{"issue":"(Kesar V.; Michel A.; Weisberg I","key":"R36-20260310","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.14309\/00000434-201310001-00470","article-title":"Mitragyna speciosa (Kratom)-induced cholestatic hepatitis","volume":"108","author":"Kesar","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"R37-20260310","first-page":"532","article-title":"Toxic hepatitis after Kratom (mitragyna sp.) consumption","volume":"49","author":"Kupferschmidt","year":"2011","journal-title":"Clin Toxicol"},{"issue":"4","key":"R38-20260310","article-title":"Acute liver injury and Kratom use: a case report","volume":"21","author":"Books","year":"2025","journal-title":"JNP- J NURSE Pract"},{"key":"R39-20260310","doi-asserted-by":"crossref","first-page":"s1275","DOI":"10.14309\/00000434-201810001-02250","article-title":"Kratom: a rare cause of hepatotoxicity","volume":"113","author":"Abushahin","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"R40-20260310","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2024.103898","article-title":"Severe jaundice with life-threatening liver failure after Kratom use: reversed by plasma exchange","volume":"63","author":"Dasgupta","year":"2024","journal-title":"Transfus Apher Sci"},{"issue":"3","key":"R41-20260310","doi-asserted-by":"crossref","first-page":"220","DOI":"10.9740\/mhc.2021.05.220","article-title":"Kratom-induced transaminitis with subsequent precipitated opioid withdrawal following naltrexone","volume":"11","author":"Jensen","year":"2021","journal-title":"Ment Health Clin"},{"issue":"5","key":"R42-20260310","doi-asserted-by":"crossref","first-page":"e550","DOI":"10.1097\/MJT.0000000000000631","article-title":"N-acetylcysteine for acute hepatitis induced by kratom herbal tea","volume":"25","author":"Mousa","year":"2018","journal-title":"Am J Ther"},{"issue":"5","key":"R43-20260310","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.japh.2018.05.006","article-title":"Possible kratom-induced hepatomegaly: a case report","volume":"58","author":"Griffiths","year":"2018","journal-title":"J Am Pharm Assoc"},{"issue":"3","key":"R44-20260310","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/hep.27612","article-title":"Cholestatic hepatitis from prolonged kratom use: a case report","volume":"61","author":"Dorman","year":"2015","journal-title":"Hepatology"},{"issue":"6","key":"R45-20260310","first-page":"1143","article-title":"Mitragyna speciosa Korth toxicity: experimental findings and future prospects","volume":"19","author":"Begum","year":"2024","journal-title":"J Taibah Univ Med Sci"},{"issue":"2","key":"R46-20260310","first-page":"131","article-title":"Acetaminophen-induced hepatotoxicity: a comprehensive update","volume":"4","author":"Yoon","year":"2016","journal-title":"J Clin Transl Hepatol"},{"issue":"10","key":"R47-20260310","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.14309\/ajg.0000000000000340","article-title":"Alcohol consumption and risk of liver cirrhosis: a systematic review and meta-analysis","volume":"114","author":"Roerecke","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"R48-20260310","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s13181-016-0588-y","article-title":"Suspected adulteration of commercial kratom products with 7-hydroxymitragynine","volume":"12","author":"Lydecker","year":"2016","journal-title":"J Med Toxicol"},{"key":"R49-20260310","doi-asserted-by":"crossref","first-page":"112701","DOI":"10.1016\/j.drugalcdep.2025.112701","article-title":"De facto opioids: characterization of novel 7-hydroxymitragynine and mitragynine pseudoindoxyl product marketing","volume":"272","author":"Hill","year":"2025","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"R50-20260310","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1089\/fpd.2022.0013","article-title":"A Multiple-Serotype Outbreak of Salmonella Infections Linked to Kratom, United States, 2017-2018","volume":"19","author":"Schwensohn","year":"2022","journal-title":"Foodborne Pathog Dis"}],"container-title":["Journal of Addiction Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ADM.0000000000001663","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:00:44Z","timestamp":1773144044000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ADM.0000000000001663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":46,"URL":"https:\/\/doi.org\/10.1097\/adm.0000000000001663","relation":{},"ISSN":["1932-0620","1935-3227"],"issn-type":[{"value":"1932-0620","type":"print"},{"value":"1935-3227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"2025-09-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}